Nicotinic Acid Hydrazide

Nicotinic Acid Hydrazide

SCHEMBL258390

NNC(=O)c1cccnc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.69
HDAC6 Q9UBN7 1/20 0.69
THRB P10828 1/20 0.68
LMNA P02545 1/20 0.62
HIF1A Q16665 1/20 0.62
F7 P08709 1/20 0.62
F3 P13726 1/20 0.62
SARM1 Q6SZW1 1/20 0.62
SIRT2 Q8IXJ6 1/20 0.62
SIRT6 Q8N6T7 1/20 0.62
SIRT1 Q96EB6 1/20 0.62
SIRT3 Q9NTG7 1/20 0.62
SIRT5 Q9NXA8 1/20 0.62
SIRT4 Q9Y6E7 1/20 0.62
ROCK2 O75116 1/20 0.61
ROCK1 Q13464 1/20 0.61
PLOD2 O00469 1/20 0.59
ALDH1A1 P00352 3/20 0.59
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nicotinic Acid Hydrazide SCHEMBL29648965 1.00 HDAC1 (0.69) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28747918 0.98 HDAC1 (0.67) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL31491467 0.98 HDAC1 (0.67) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28127107 0.94 HDAC1 (0.62) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28112815 0.91 HDAC1 (0.59) HDAC1HDAC6THRBLMNAHIF1A
Benzoic Acid Hydrazide SCHEMBL5778873 0.88 GAA (0.70) HDAC1HDAC6THRBF7F3
SCHEMBL2833544 0.87 ROCK2 (0.69) HDAC1HDAC6LMNAHIF1AROCK2
Nicotinic Acid Hydrazide SCHEMBL28304573 0.86 NAPRT (0.61) HDAC1HDAC6THRBLMNAPLOD2
SCHEMBL1019295 0.85 HDAC1 (0.65) HDAC1HDAC6THRBLMNAHIF1A
Nicotinic Acid Hydrazide SCHEMBL28304575 0.84 HCAR2 (0.57) HDAC1HDAC6THRBLMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 997 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080895-A Polyglycolic acid composition and preparation method thereof, biodegradable polyester material and application thereof, and PGA temporary plugging ball and preparation method thereof 2026-05-26 CN claimed
CN-119391251-B Super-hydrophobic anti-icing coating for power transmission line and preparation method thereof 和通数联(北京)科技工程有限公司 2025-04-18 CN claimed
CN-118994321-B Preparation method and application of cosmetic cyclic peptide reagent 杭州皓阳生物技术有限公司 2025-02-14 CN claimed
US-20250051805-A1 METHODS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2025-02-13 US claimed
CN-119391251-A Super-hydrophobic anti-icing coating for power transmission line and preparation method thereof 和通数联(北京)科技工程有限公司 2025-02-07 CN claimed
CN-118994321-A Preparation method and application of cosmetic cyclic peptide reagent 杭州皓阳生物技术有限公司 2024-11-22 CN claimed
CN-118638274-A Polyvinyl alcohol microsphere and preparation method and application thereof 湖南埃普特医疗器械有限公司 2024-09-13 CN claimed
US-12071503-B2 Method for preparing and repairing covalent organic framework materials ZHEJIANG UNIVERSITY (CN) 2024-08-27 US claimed
CN-118359536-A Novel-structure compound and application thereof in aspect of cryopreservation protection of stem cells 南京泓纬医药科技有限公司 2024-07-19 CN claimed
US-20240239765-A1 GLYCINE N-METHYLTRANSFERASE SPECIFIC ENHANCER AND PREPARATION METHOD AND USES THEREOF KAOHSIUNG MEDICAL UNIVERSITY (TW) 2024-07-18 US claimed
EP-1392219-A4 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF CYTOVIA INC (US) 2007-01-24 EP claimed
US-20040186078-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2004-09-23 US claimed
EP-1392219-A2 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOTOSIS AND THE USE THEREOF Cytovia, Inc. (US) 2004-03-03 EP claimed
US-20030013743-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2003-01-16 US claimed
WO-2002089745-A2 SUBSTITUTED N'-(ARYLCARBONYL)-BENZHYDRAZIDES, N'-(ARYLCARBONYL)-BENZYLIDENE-HYDRAZIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-11-14 WO claimed
EP-0322691-B1 Process for producing 1-acyl-2-pyrazoline derivatives MITSUI TOATSU CHEMICALS (JP) 1994-06-15 EP claimed
US-4956301-A Test for diagnosis of diabetes, pads with indicators sensitive to fructosamine MILES INC. (US) 1990-09-11 US claimed
EP-0274928-A2 Use of xanthine-oxydase inhibitors in the manufacture of a pharmaceutical composition for the treatment of glaucoma, and pharmaceutical compositions for the treatment of glaucoma LABORATOIRES CHAUVIN (FR) 1988-07-20 EP claimed
EP-0214158-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-03-18 EP claimed
WO-1986004582-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1986-08-14 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186078-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP2, CASP1, BCL2 HDAC1 34/4885HDAC6 102/4885THRB 2238/4885
US-20240239765-A1 GLYCINE N-METHYLTRANSFERASE SPECIFIC ENHANCER AND PREPARATION METHOD AND USES THEREOF GNMT, NNMT, HNMT HDAC1 733/4885HDAC6 2260/4885THRB 1935/4885
US-20250051805-A1 METHODS BRDT, BRPF3, BRD4 HDAC1 422/4885HDAC6 719/4885THRB 2974/4885
US-20030013743-A1 Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP2, CASP1, BCL2 HDAC1 34/4885HDAC6 102/4885THRB 2238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.